Clinical Trial Update: A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing selumetinib to carboplatin/vincristine in patients with neurofibromatosis type 1-associated low-grade glioma, with the study currently l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma
• Neurofibromatosis Type
• Optic Pathway Glioma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Koselugo (selumetinib)
• Vincristine (vincristine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Low Grade Glioma, Neurofibromatosis Type 1 | Phase 3 | Status: ACTIVE_NOT_RECRUITING